Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

WIMM Professor Ahmed Ahmed, along with Martin Drysdale from the Beatson Institute in Glasgow and Stefan Knapp (TDI, Oxford) have been awarded a substantial DPFS (Developmental Pathway Funding Scheme) grant (~£1.9M) from the MRC.  The grant will support intensive medicinal chemistry efforts, structural biology and preclinical evaluation to develop novel small molecule inhibitor of SIK2 for ovarian cancer therapy.